Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.039 AUD
−5.91 M AUD
5.35 M AUD
About CONTROL BIONICS LIMITED
Sector
Industry
CEO
Jeremy E Steele
Website
Headquarters
Camberwell
Founded
2005
ISIN
AU0000114183
FIGI
BBG00Y540M48
Control Bionics Ltd. engages in the manufacture, design, and sale of wireless wearable electromyography (EMG) based augmentative and alternative communication (AAC) technology. It operates through the following segments: Australia, US, International, R&D, and Corporate. The Australia segment is involved with the sales of Trilogy units and components in Australia. The US segment refers to Manufacture and sales of Trilogy units and components in North America. The International segment deals with the activities undertaken to establish viable and additional operating segments. The R&D segment pertains to the Research activities undertaken regarding the Group's products. The Corporate segment offers support, regulatory and infrastructure activities, and elimination entries above the EBITDA line. The company was founded by Peter Shann Ford in 2005 and is headquartered in Sydney, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CBL is 0.058 AUD — it hasn't changed in the past 24 hours. Watch CONTROL BIONICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange CONTROL BIONICS LIMITED stocks are traded under the ticker CBL.
CBL stock has fallen by −13.43% compared to the previous week, the month change is a −3.33% fall, over the last year CONTROL BIONICS LIMITED has showed a 34.88% increase.
CBL stock is 0.00% volatile and has beta coefficient of 2.17. Track CONTROL BIONICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is CONTROL BIONICS LIMITED there?
Yes, you can track CONTROL BIONICS LIMITED financials in yearly and quarterly reports right on TradingView.
CONTROL BIONICS LIMITED is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
CBL net income for the last half-year is −3.72 M AUD, while the previous report showed −2.19 M AUD of net income which accounts for −70.01% change. Track more CONTROL BIONICS LIMITED financial stats to get the full picture.
No, CBL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CONTROL BIONICS LIMITED EBITDA is −6.02 M AUD, and current EBITDA margin is −112.56%. See more stats in CONTROL BIONICS LIMITED financial statements.
Like other stocks, CBL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONTROL BIONICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CONTROL BIONICS LIMITED technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CONTROL BIONICS LIMITED stock shows the sell signal. See more of CONTROL BIONICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.